Healthcare Industry News: Pericardium Covered Stent
News Release - June 2, 2008
Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great DeliverabilityOR AKIVA, Israel, June 2 (HSMN NewsFeed) -- ITGI Medical, Ltd. (TASE: ITGI) announced today the first commercial use of the CE certified Over and Under® Pericardium Covered Stent (PCS) in the UK
The first Over and Under® PCS commercial implantation and first implantation in the UK was performed at the Royal Bournemouth Hospital whose Percutaneous Coronary Intervention Leader is Dr. Suneel Talwar and the procedure was performed by the Cath Lab director Dr. Rosie Swallow. The medical team granted the procedure as a success due to the special characteristics of the stent and the ease at which the stent was delivered to the lesion.
A pilot study designed to compare the deliverability of a PTFE covered stent vs. Over and Under® PCS was presented by Dr. Haim Danenberg, Head of Interventional Cardiology Unit and the company's medical director, at the annual EuroPCR meeting. Study was performed in phantom and porcine coronaries. Over and Under® PCS appeared to be significantly superior in deliverability in both model systems.
At its initial step, ITGI launched Over and Under® PCS in England, in collaboration with Pyramed, the UK distributor. "We are very pleased with Pyramed's marketing. They have recently purchased the stents and already managed to initiate its use," commented Efri Argaman, CEO of ITGI Medical, "The medical team's satisfaction strengthens our belief that Over and Under® PCS ushers in a new era for interventional medicine."
About Over and Under®
Over and Under® is a unique stent, first in a series of heterologous tissue covered stents, designed to set a barrier between the blood vessel wall and its lumen. Over and Under® PCS is indicated for treatment of bypass stenosis, aneurysms and for emergency situations such as perforations.
About ITGI Medical
ITGI medical is engaged with research and development, manufacturing and marketing of heterologous tissue covered stents. Over and Under® is the first among series of heterologous covered stents designed to treat coronary lesions and aneurysms.
Source: ITGI Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.